Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   Unraveling the dynamics of B7-H3-targeting therapeutic antibodies in cancer through PET imaging and antibody pharmacokinetics
  2. Fernandes, Bruna; Olkowski, Colleen P; Ghaemi, Behnaz; Basuli, Falguni; Shi, Jianfeng; Kiesewetter, Dale O; Lang, Lixin; Elijah, Edmondson; Swenson, Rolf; Choyke, Peter L; Lin, Frank I; Jacobson, Orit
  3. Journal of Controlled Release : official journal of the Controlled Release Society. 2025, Jan 13;
  1. 2.   Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability
  2. Feng,Yang; Lee,Jaewon; Yang,Liping; Hilton,Mary; Morris,Karen; Seaman,Steven; Edupuganti,Shivaji; Hsu,Kuo-Sheng; Dower, Christopher; Yu,Guojun; So,Daeho; Bajgain,Pradip; Zhu, Zhongyu; Dimitrov, Dimiter S; Patel,Nimit; Robinson,Christina; Difilippantonio,Simone; Dyba,Marzena; Corbel,Amanda; Basuli, Falguni; Swenson, Rolf E; Kalen,Joseph; Suthe, Sreedhar Reddy; Hussain, Myer; Italia, James S; Souders, Colby A; Gao, Ling; Schnermann,Martin; St Croix,Brad
  3. Cell Reports. 2023, Nov 28; 42(12): 113503.
  1. 3.   Advanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibody
  2. Lee, Myungeun; Lu, Zhi Hong; Shoemaker, Charles B.; Tremblay, Jacqueline M.; St Croix,Brad; Seaman,Steven; Gonzalez-Pastor, Rebeca; Kashentseva, Elena A.; Dmitriev, Igor P.; Curiel, David T.
  3. Journal of Controlled Release : Official Journal of the Controlled Release Society. 2021, Jun 10; 334: 106-113.
  1. 4.   The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models
  2. Kendsersky, Nathan M.; Lindsay, Jarrett; Kolb, E. Anders; Smith, Malcolm A.; Teicher, Beverly A.; Erickson, Stephen W.; Earley, Eric J.; Mosse, Yael P.; Martinez, Daniel; Pogoriler, Jennifer; Krytska, Kateryna; Patel, Khushbu; Groff, David; Tsang, Matthew; Ghilu, Samson; Wang, Yifei; Seaman,Steven; Feng,Yang; St Croix,Brad; Gorlick, Richard; Kurmasheva, Raushan; Houghton, Peter J.; Maris, John M.
  3. CLINICAL CANCER RESEARCH. 2021, May 15; 27(10): 2938-2946.
  1. 5.   Isolation of rabbit single domain antibodies to B7-H3 via protein immunization and phage display
  2. Feng, Ruonan; Wang, Ruixue; Hong, Jessica; Dower,Chris; St Croix,Brad; Ho, Mitchell
  3. Antibody therapeutics. 2020, Jan; 3(1): 10-17.
  1. 6.   Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature
  2. Seaman, Steven; Zhu, Zhongyu; Saha, Saurabh; Zhang, Xiaoyan M; Yang, Mi Young; Hilton, Mary; Morris, Karen; Szot, Christopher; Morris, Holly; Swing, Debbie; Tessarollo, Lino; Smith, Sean W; Degrado, Sylvia; Borkin, Dmitry; Jain, Nareshkumar; Scheiermann, Julia; Feng, Yang; Wang, Yanping; Li, Jinyu; Welsch, Dean; DeCrescenzo, Gary; Chaudhary, Ritu; Zudaire, Enrique; Klarmann, Kimberly; Keller, Jonathan; Dimitrov, Dimiter; St Croix, Brad
  3. Cancer Cell. 2017, Apr 10; 31(4): 501-515.e8.
  1. 7.   Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10
  2. Rodriguez-Garcia, M.; Porichis, F.; de Jong, O. G.; Levi, K.; Diefenbach, T. J.; Lifson, J. D.; Freeman, G. J.; Walker, B. D.; Kaufmann, D. E.; Kavanagh, D. G.
  3. Journal of Leukocyte Biology. 2011, Apr; 89(4): 507-515.
  1. 8.   Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain
  2. Spuches, A. M.; Argiros, H. J.; Lee, K. H.; Haas, L. L.; Perch, S. C.; Krag, D. N.; Roller, P. P.; Wilcox, D. E.; Lyons, B. A.
  3. Journal of Molecular Recognition. 2007, Jul-Aug; 20(4): 245-252.
  1. 9.   Alloantigenic stimulation bypasses CD28-B7 costimulatory blockade by an interleukin-2-dependent mechanism
  2. Blazevic, V.; Pinto, L. A.; Mac Trubey, C.; Shearer, G. M.
  3. Journal of Leukocyte Biology. 2000 67(6): 817-824.
  1. 10.   Engagement of the OX-40 receptor in vivo enhances antitumor immunity
  2. Weinberg, A. D.; Rivera, M. M.; Prell, R.; Morris, A.; Ramstad, T.; Vetto, J. T.; Urba, W. J.; Alvord, G.; Bunce, C.; Shields, J.
  3. Journal of Immunology. 2000 164(4): 2160-2169.
  1. 11.   Mechanisms for induction of acquired host immunity by neutrophil peptide defensins
  2. Lillard, J. W.; Boyaka, P. N.; Chertov, O.; Oppenheim, J. J.; McGhee, J. R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(2): 651-656.
  1. 12.   Induction of Melanoma Antigen-Specific Cytotoxic T Lymphocytes in Vitro By Stimulation With B7-Expressing Human Melanoma Cell Lines
  2. Fenton, R. G.; Turcovskicorrales, S. M.; Taub, D. D.
  3. Journal of Immunotherapy. 1998 21(2): 95-108.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel